RecruitingNot ApplicableNCT05687396

Virtual Reality in COPD Exacerbation

Virtual Reality in Chronic Obstructive Pulmonary Disease: Randomized Contolled Trial


Sponsor

Pamukkale University

Enrollment

50 participants

Start Date

Jun 1, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

In addition to conventional pulmonary rehabilitation, virtual reality will be applied during the hospitalization period of individuals hospitalized for COPD exacerbation. It is aimed to get more efficiency from the interventions in this short time.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Individuals who are in COPD exacerbation period, FEV1 \<70%, GOLD 2-3 spirometric stage, Hodkinson mental test score \> 6 and who want to participate in the study voluntarily will be included in the study.

Exclusion Criteria1

  • If there is respiratory disease considered more significant than COPD (bronchiectasis, lung cancer requiring active therapy, or asthma), Heart failure New York Heart Association (NYHA) stage 3-4, Significant hemoptysis, surgical or non-surgical lung volume in the past 6 months Individuals with reduction procedures, Lung transplantation or pneumonectomy surgery in the last 6 months, pulmonary embolism or pulmonary edema, acute myocardial infarction, acute heart failure, vertigo, epilepsy and visual impairment will be excluded from the study.

Interventions

DEVICEvirtual reality

virtual reality designed as cycling in the forest

OTHERconventional pulmonary rehabilitation

pulmonary rehabilitation


Locations(1)

Pamukkale University

Denizli, Pamukkale, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05687396


Related Trials